Watch for Acid-Reducer Interactions With New Hep C Med Harvoni

December 2014

Please see new warnings concerning the use of amiodarone with Harvoni or Sovaldi

You'll see two new ORAL hepatitis C regimens...Harvoni (har-VOE-nee) and Galexos (simeprevir) PLUS Sovaldi (sofosbuvir).

These new regimens are changing hep C therapy again...because they eliminate the need for ribavirin and interferon for most patients.

Harvoni is a new once-daily tablet that combines Sovaldi with a new antiviral, ledipasvir.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Respiratory & Allergy Use the "Rule of Two" to Help Improve Asthma Care
Gastroenterology Explain it May Take 3 to 5 Days to Feel the Full Effect of Olex
Hepatitis C Watch for Acid-Reducer Interactions With New Hep C Med Harvoni
Opioids Suggest an NSAID Instead of Opioids for Chronic Musculoskeletal Pain
Diabetes Remind Patients to Gently Mix "Cloudy" Insulins...Even in Pens
Women's Health Point Out IUDs are the Most Effective Contraceptive
Corticosteroids Advise Patients to Report Psychiatric Effects With Steroids
Influenza Save Flu Antivirals for Severely Ill or High-Risk Patients
Diarrhea Tell Patients There's Not Much Evidence That Travelanis Effective
Cannabinoids Advise Against Medical Marijuana for Low Back Pain or Fibromyalgia
Wound Care Don't Assume Expensive Wound Dressings Work Better
Infection Control Use Soap and Water After C. difficile or Norovirus Exposure
Antithrombotics Emphasize Daily Adherence With the New Oral Anticoagulants After Cardioversion